Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
2(40%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_2
2
40%
Ph phase_1
1
20%
Ph early_phase_1
1
20%
Ph phase_3
1
20%

Phase Distribution

2

Early Stage

2

Mid Stage

1

Late Stage

Phase Distribution5 total trials
Early Phase 1First-in-human
1(20.0%)
Phase 1Safety & dosage
1(20.0%)
Phase 2Efficacy & side effects
2(40.0%)
Phase 3Large-scale testing
1(20.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

50.0%

1 of 2 finished

Non-Completion Rate

50.0%

1 ended early

Currently Active

2

trials recruiting

Total Trials

5

all time

Status Distribution
Active(2)
Completed(1)
Terminated(1)
Other(1)

Detailed Status

Recruiting1
Withdrawn1
Completed1
unknown1
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
2
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Early Phase 11 (20.0%)
Phase 11 (20.0%)
Phase 22 (40.0%)
Phase 31 (20.0%)

Trials by Status

recruiting120%
withdrawn120%
completed120%
unknown120%
active_not_recruiting120%

Recent Activity

Clinical Trials (5)

Drug Details

Intervention Type
DRUG
Total Trials
5